Charles River Laboratories (CRL) Q3 revenue $982.7 million vs $968 million est.; adj. EPS $3.09 vs $3.00 est.; raises full-year guidance
Open the sourceReported by SEC EDGAR, sec.gov, 4 November 2026, by SEC EDGAR
Not scored
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at sec.gov.
Named in this story
A linked name opens that asset's sentiment page.